Subscribe
shutterstock_1405481684_whitemocca
whiteMocca / Shutterstock.com
28 April 2020Europe

Webinar: How do you patent healthcare AI?

Judging by today’s news cycle, you might think that the world of IP is quite advanced when it comes to artificial intelligence (AI).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Genetics
Webinar: Plenty to fight for in CRISPR IP battle
26 March 2020   Despite a recent swing in momentum to the University of California, it’s still too early to say who is likely to emerge triumphant in the CRISPR patent battle.
Big Pharma
HGF promotes two to partner
11 May 2020   IP firm HGF has appointed two patent attorneys to partner, increasing the partner group to 63 partners.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Big Pharma
HGF promotes two to partner
11 May 2020   IP firm HGF has appointed two patent attorneys to partner, increasing the partner group to 63 partners.
Genetics
Webinar: Plenty to fight for in CRISPR IP battle
26 March 2020   Despite a recent swing in momentum to the University of California, it’s still too early to say who is likely to emerge triumphant in the CRISPR patent battle.

More on this story

Big Pharma
HGF promotes two to partner
11 May 2020   IP firm HGF has appointed two patent attorneys to partner, increasing the partner group to 63 partners.
Genetics
Webinar: Plenty to fight for in CRISPR IP battle
26 March 2020   Despite a recent swing in momentum to the University of California, it’s still too early to say who is likely to emerge triumphant in the CRISPR patent battle.

More features

GSK triumphs in EPO appeal, revoking Pfizer patent
‘We took Ravgen head-on’: How we won zero-damages and others didn't
Kathi Vidal to leave USPTO ahead of incoming Trump administration
Herbert Smith Freehills and Kramer Levin in $2bn merger talks
Teva fights for re-listing of inhaler patents at US appeals court
CRISPR patents revoked following Nobel Prize winners’ withdrawal
White & Case hires experienced litigator from A&O Shearman
President Trump 2.0: Five major areas to watch